Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Bioasis and Wuxi Biologics announced an initial strategic collaboration for the development and manufacturing of xB3-001, Bioasis’ lead investigational biological candidate to treat brain cancer.
read more
Monday, September 18, 2017
BioAxone BioSciences announced it is the recipient of a grant award from the NINDS, part of the agency's SBIR Phase II funding program.
read more
Wednesday, November 29, 2017
BIOCAD and Sothema Labs announced the launch of medicines derived using the technology provided by the Russian manufacturer into the North African market.
read more
Biocare Medical has announced a collaborative partnership with Bethyl Laboratories to develop targeted antibodies for cancer research and oncology diagnostics.
read more
Tuesday, December 17, 2024
BioCentriq has entered into a long-term lease agreement with National Business Parks for a state-of-the-art cell therapy manufacturing facility in Princeton, New Jersey. The facility will serve as the company's new headquarters and will include an ...
read more
Wednesday, February 19, 2020
Biocept has entered into an agreement with a California-based IPA to provide its liquid biopsy testing services to physicians and patients in their network.
read more
Thursday, October 07, 2021
BioCina, a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of microbial-based therapeutics and mRNA vaccines announces the full and final transition from Hospira Adelaide ...
read more
BioCina announced it has initiated a comprehensive CMC (Chemistry, Manufacturing, and Controls) program for the advancement of RLS-2201, a proprietary injectable formulation of Quetiapine being developed by Patrys for the acute treatment of delirium ...
read more
BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful ...
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, announced that it is, together with C.R. Bard, a 2012 winner of Microsoft Corporation’s prestigious Life Sciences Innovation Award. The awards, announced at the Drug ...
read more
BioClinica, Inc., a global provider of clinical trial management services, announced today that JLL Partners and Ampersand Capital Partners, two leading middle market private equity firms, have completed their acquisition of BioClinica and CoreLab ...
read more
BioClinica®, Inc., a global provider of clinical trial management services, has recently announced several major initiatives to better serve its growing sponsor client base in China and other Asia Pacific countries, following its March 2013 merger ...
read more
BioClinica®, Inc., a global provider of clinical trial management solutions, announced today the introduction of StudyView™, a clinical trials portal and reporting hub that dramatically increases clinical trials operational visibility. StudyView ...
read more
Bioclinica® has assembled a team of experts dedicated to NAFLD and NASH to help sponsors develop therapeutics using medical imaging and other biomarkers in clinical trials.
read more
BioClinica®, Inc., has announced that David Peters, an accomplished senior finance and accounting executive, has been named Executive Vice President and Chief Financial Officer (CFO) and will be joining BioClinica on June 8, 2015.
read more